Organigram

Moncton, CanadaFounded 2013

Producer & Grower NASDAQ: OGI www.organigram.ca

Share:X / Twitter LinkedIn Suggest a correction

About Organigram

Organigram is a Moncton, New Brunswick-based licensed producer known for its innovation-driven approach to cannabis production. The company received a strategic investment from British American Tobacco and has been recognized for leading market share in several Cannabis 2.0 product categories including edibles and vapes.

Key Facts

1British American Tobacco invested CAD $221 million for a 19.9% stake, with a product development collaboration
2SHRED brand became one of the best-selling cannabis products in Canada
3Operates a state-of-the-art indoor cultivation facility in Moncton, New Brunswick
4Invested in Jupiter Research for next-generation vape technology

Latest News

Organigram Holdings Near 52-Week Low as Cannabis Sector Struggles

3d ago

OGI trades at $0.87, just 2% above its 52-week low of $0.85, reflecting broader cannabis industry challenges and company-specific pressures.

OGI Stock Tests Canadian Cannabis Profit Viability Amid Sector Shakeout

8d ago

Organigram Holdings faces critical profitability challenges as Canada's cannabis market consolidates around sustainable operators.

Organigram Outlines Strategic Vision as Cannabis Volatility Persists

13d ago

OGI management details operational priorities and market positioning strategy while cannabis sector faces continued price pressure and uncertainty.

View all OGI news

Frequently Asked Questions

What is the SHRED brand?

SHRED is Organigram's highly successful milled flower brand that disrupted the Canadian cannabis market with its ready-to-roll format, becoming one of the top-selling cannabis SKUs nationally.

What is Organigram's relationship with BAT?

British American Tobacco invested CAD $221 million for a 19.9% stake in Organigram and established a product development collaboration called the Centre of Excellence to develop next-generation cannabis products.